Regulus Therapeutics

1 follower

Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.

Employees

51-200

Links


Org chart

Preston S. Klassen
President, Head of R&D
Christopher Aker
SVP & General Counsel
Claire Padgett
SVP, Clinical Operations
Brian Campion
Vice President, Business Development
Cris Calsada
Chief Financial Officer
Gina S.
Sr. Manager, Operations & Human Resources Administration
Morgan Carlson
Vice President, Biology
Firuz Shakoori
Head Of GMP Manufacturing & Supply
Edmund Lee
VP, Translational Medicine

Board & advisors